news
Genmab appoints Judith Klimovsky as Chief Development Officer
The biotechnology company Genmab announced today the appointment of Judith Klimovsky, MD, as Executive Vice President and Chief Development Officer.
List view / Grid view
Bristol-Myers Squibb
news
AbbVie and Bristol-Myers Squibb announce lung cancer clinical trials collaboration
25 July 2016 | By Niamh Louise Marriott, Digital Content Producer
AbbVie and Bristol-Myers Squibb Company today announced a clinical trial collaboration to evaluate the safety, tolerability and efficacy of AbbVie’s investigational biomarker-specific antibody drug conjugate Rova-T...
news
Bristol-Myers Squibb to acquire Padlock Therapeutics
23 March 2016 | By Victoria White
Padlock Therapeutics is a private biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases...
news
A step towards the male contraceptive pill
13 March 2016 | By Victoria White
A group of researchers has taken a step toward a male contraceptive pill by tweaking some experimental compounds that show promise...
news
Bristol-Myers Squibb teams up with LabCentral to support promising biotech startups
7 March 2016 | By Victoria White
LabCentral is an innovative, shared laboratory space designed as a launch pad for life-sciences and biotech startups...
news
BMS and Dana-Farber Cancer Institute enter I-O RPM collaboration
16 February 2016 | By Victoria White
As part of the I-O RPM programme, Bristol-Myers Squibb and Dana-Farber Cancer Institute will conduct a range of early phase clinical studies...
news
ADDoPT project set to transform the UK pharma industry
28 January 2016 | By Victoria White
The ADDoPT project addresses the key challenge of getting new innovative medicines to market in the quickest and most cost-effective way...
news
Oncodesign and BMS enter drug discovery collaboration
5 January 2016 | By Victoria White
Oncodesign and Bristol-Myers Squibb have entered into a strategic collaboration to discover, develop and commercialise novel macrocyclic compounds...
news
BMS and UCLA team up for immuno-oncology collaboration
14 December 2015 | By Victoria White
Bristol-Myers Squibb and the David Geffen School of Medicine at UCLA will conduct a range of early phase clinical studies as part of the I-O RPM research programme...
news
LSP and Bristol-Myers Squibb team up for life sciences innovation
24 November 2015 | By Victoria White
The companies have said they will focus is on immuno-oncology, one of the hottest and most dynamic areas in biotechnology...
news
BMS and Moffitt form immuno-oncology partnership
25 September 2015 | By Victoria White
Bristol-Myers Squibb and Moffitt will conduct a range of early phase clinical studies, including clinical investigations by young investigators to strengthen their development as clinical research scientists...
news
Bristol-Myers Squibb and QIMR Berghofer Medical Research Institute announce worldwide collaboration to discover novel Immuno-Oncology Antibodies
1 September 2015 | By Charlotte Batchelor
Bristol-Myers Squibb Company and QIMR Berghofer Medical Research Institute have signed a research collaboration and license agreement to discover novel therapeutic antibodies against an undisclosed immuno-oncology...
news
MUSC and Bristol-Myers Squibb announce research collaboration focused on fibrotic diseases
15 July 2015 | By Victoria White
MUSC and Bristol-Myers Squibb have entered into a research collaboration focused on fibrotic diseases, including scleroderma and renal fibrosis...
news
Bristol-Myers Squibb expands R&D presence in the US
25 June 2015 | By Victoria White
Bristol-Myers Squibb Company has announced important next steps in the evolution of the Company’s R&D organisation...
news
Lexicon and Bristol-Myers Squibb select development candidate for neuropathic pain
15 April 2015 | By Victoria White
Lexicon and Bristol-Myers Squibb have selected a development candidate for neuropathic pain as part of their drug discovery and development alliance...
